| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3988711 | Journal of Cancer Policy | 2016 | 4 Pages |
Abstract
•Information is a very critical issue for patient access to new emerging drugs in rare cancer trials.•Information process must be accurately managed in all phases of the trials.•Information is crucial for patient awareness, empowerment, involvement and participation.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ornella Gonzato,